Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?

Lehtola H, Hartikainen J, Hartikainen P, Kiviniemi T, Nuotio I, Palomäki A, Ylitalo A, Airaksinen KEJ, Mustonen P.

Clin Cardiol. 2018 May;41(5):608-614. doi: 10.1002/clc.22935. Epub 2018 May 10.

2.

MANTA versus ProGlide vascular closure devices in transfemoral transcatheter aortic valve implantation.

Biancari F, Romppanen H, Savontaus M, Siljander A, Mäkikallio T, Piira OP, Piuhola J, Vilkki V, Ylitalo A, Vasankari T, Airaksinen JKE, Niemelä M.

Int J Cardiol. 2018 Jul 15;263:29-31. doi: 10.1016/j.ijcard.2018.04.065. Epub 2018 Apr 14.

PMID:
29681408
3.

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study).

Jaakkola S, Kiviniemi TO, Nuotio I, Hartikainen J, Mustonen P, Palomäki A, Jaakkola J, Ylitalo A, Hartikainen P, Airaksinen KEJ.

Am J Cardiol. 2018 May 15;121(10):1182-1186. doi: 10.1016/j.amjcard.2018.01.038. Epub 2018 Feb 12.

PMID:
29526276
4.

Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up.

Pääkkö TJW, Perkiömäki JS, Kesäniemi YA, Ylitalo AS, Lumme JA, Huikuri HV, Ukkola OH.

J Hum Hypertens. 2018 Mar;32(3):180-189. doi: 10.1038/s41371-018-0034-5. Epub 2018 Feb 7.

PMID:
29416118
5.

Ambulatory Pulse Pressure Predicts the Development of Left Ventricular Diastolic Dysfunction in Over 20 Years of Follow-up.

Pääkkö TJW, Renko RJ, Perkiömäki JS, Kesäniemi YA, Ylitalo AS, Lumme JA, Huikuri HV, Ruskoaho H, Vuolteenaho O, Ukkola OH.

Am J Hypertens. 2017 Oct 1;30(10):985-992. doi: 10.1093/ajh/hpx087.

PMID:
28911024
6.

Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk.

Lehtola H, Airaksinen KEJ, Hartikainen P, Hartikainen JEK, Palomäki A, Nuotio I, Ylitalo A, Kiviniemi T, Mustonen P.

Eur J Neurol. 2017 May;24(5):719-725. doi: 10.1111/ene.13280. Epub 2017 Mar 20.

PMID:
28317289
7.

Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study.

Bah A, Nuotio I, Grönberg T, Ylitalo A, Airaksinen KE, Hartikainen JE.

Ann Med. 2017 May;49(3):254-259. doi: 10.1080/07853890.2016.1267869. Epub 2016 Dec 31.

PMID:
28042730
8.

Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).

Jaakkola S, Lip GY, Biancari F, Nuotio I, Hartikainen JE, Ylitalo A, Airaksinen KE.

Am J Cardiol. 2017 Mar 1;119(5):749-752. doi: 10.1016/j.amjcard.2016.11.026. Epub 2016 Dec 2.

PMID:
28017305
9.

Stroke as the First Manifestation of Atrial Fibrillation.

Jaakkola J, Mustonen P, Kiviniemi T, Hartikainen JE, Palomäki A, Hartikainen P, Nuotio I, Ylitalo A, Airaksinen KE.

PLoS One. 2016 Dec 9;11(12):e0168010. doi: 10.1371/journal.pone.0168010. eCollection 2016.

10.

Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial.

Karjalainen PP, Nammas W, Kervinen K, de Belder A, Rivero-Crespo F, Ylitalo A, Airaksinen JK.

J Interv Cardiol. 2017 Apr;30(2):114-123. doi: 10.1111/joic.12357. Epub 2016 Dec 7.

PMID:
27925308
11.

Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).

Karjalainen PP, Niemelä M, Laine M, Airaksinen JK, Ylitalo A, Nammas W.

Am J Cardiol. 2017 Feb 1;119(3):345-350. doi: 10.1016/j.amjcard.2016.09.057. Epub 2016 Nov 1.

PMID:
27887689
12.

Ambulatory Blood Pressure Characteristics and Long-Term Risk for Atrial Fibrillation.

Perkiömäki JS, Nortamo S, Ylitalo A, Kesäniemi A, Ukkola O, Huikuri HV.

Am J Hypertens. 2017 Mar 1;30(3):264-270. doi: 10.1093/ajh/hpw149.

PMID:
27852579
13.

Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.

Palomäki A, Kiviniemi T, Mustonen P, Odei C, Hartikainen JEK, Nuotio I, Ylitalo A, Hartikainen P, Biancari F, Airaksinen KEJ.

Int J Cardiol. 2017 Jan 15;227:869-874. doi: 10.1016/j.ijcard.2016.06.107. Epub 2016 Jun 23.

PMID:
27639597
14.

Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.

Karjalainen PP, Nammas W, Ylitalo A, de Bruyne B, Lalmand J, de Belder A, Rivero-Crespo F, Kervinen K, Airaksinen JKE.

Int J Cardiol. 2016 Nov 1;222:275-280. doi: 10.1016/j.ijcard.2016.07.267. Epub 2016 Aug 1.

PMID:
27497110
15.

Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.

Palomäki A, Kiviniemi T, Hartikainen JE, Mustonen P, Ylitalo A, Nuotio I, Hartikainen P, Jaakkola J, Luite R, Airaksinen KE.

Clin Cardiol. 2016 Aug;39(8):471-6. doi: 10.1002/clc.22554. Epub 2016 May 30.

16.

Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).

Grönberg T, Hartikainen JE, Nuotio I, Biancari F, Ylitalo A, Airaksinen KE.

Am J Cardiol. 2016 Apr 15;117(8):1294-8. doi: 10.1016/j.amjcard.2016.01.024. Epub 2016 Jan 29.

PMID:
26892448
17.

Renal sympathetic denervation in treating drug-resistant hypertension in a patient on hemodialysis.

Pietilä-Effati PM, Salmela AK, Niemi RT, Ylitalo AS, Koistinen MJ.

J Hypertens. 2016 Feb;34(2):368-70. doi: 10.1097/HJH.0000000000000802.

PMID:
26867061
18.

Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.

Karjalainen P, Paana T, Ylitalo A, Sia J, Nammas W.

Acta Radiol. 2017 Sep;58(9):1077-1084. doi: 10.1177/0284185116683573. Epub 2016 Dec 19.

PMID:
28273737
19.

Strokes after cardioversion of atrial fibrillation--The FibStroke study.

Palomäki A, Mustonen P, Hartikainen JE, Nuotio I, Kiviniemi T, Ylitalo A, Hartikainen P, Lehtola H, Luite R, Airaksinen KE.

Int J Cardiol. 2016 Jan 15;203:269-73. doi: 10.1016/j.ijcard.2015.10.168. Epub 2015 Oct 20.

PMID:
26519683
20.

Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.

Palomäki A, Mustonen P, Hartikainen JE, Nuotio I, Kiviniemi T, Ylitalo A, Hartikainen P, Airaksinen KE.

Eur J Neurol. 2016 Jan;23(1):133-9. doi: 10.1111/ene.12820. Epub 2015 Aug 11.

PMID:
26263442
21.

Renal Impairment and Prognosis of Patients with Atrial Fibrillation Undergoing Coronary Intervention - The AFCAS Trial.

Lahtela HM, Kiviniemi TO, Puurunen MK, Schlitt A, Rubboli A, Ylitalo A, Valencia J, Lip GY, Airaksinen KE.

PLoS One. 2015 Jun 1;10(6):e0128492. doi: 10.1371/journal.pone.0128492. eCollection 2015.

22.

Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study.

Jaakkola J, Hartikainen JE, Kiviniemi T, Nuotio I, Nammas W, Grönberg T, Karmi A, Ylitalo A, Airaksinen KE.

Ann Med. 2015 Jun;47(4):341-5. doi: 10.3109/07853890.2015.1031821. Epub 2015 May 6.

PMID:
25943162
23.

Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study.

Grönberg T, Hartikainen JE, Nuotio I, Biancari F, Vasankari T, Nikkinen M, Ylitalo A, Airaksinen KE.

Pacing Clin Electrophysiol. 2015 Mar;38(3):368-75. doi: 10.1111/pace.12561. Epub 2014 Dec 23.

PMID:
25534241
24.

Early neointimal coverage and vasodilator response following biodegradable polymer sirolimus-eluting vs. durable polymer zotarolimus-eluting stents in patients with acute coronary syndrome –HATTRICK-OCT trial.

Karjalainen PP, Varho V, Nammas W, Mikkelsson J, Pietilä M, Ylitalo A, Airaksinen JK, Sia J, Nyman K, Biancari F, Kiviniemi T.

Circ J. 2015;79(2):360-7. doi: 10.1253/circj.CJ-14-1000. Epub 2014 Dec 15.

25.

Mid-term clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: OPTIMAX first-in-man study.

Karjalainen PP, Mikkelsson J, Ylitalo A, Paana T, Nammas W.

Rev Esp Cardiol (Engl Ed). 2014 Nov;67(11):958-9. doi: 10.1016/j.rec.2014.06.012. Epub 2014 Sep 18. No abstract available.

PMID:
25241027
26.

Prognostic significance of impaired baroreflex sensitivity assessed from Phase IV of the Valsalva maneuver in a population-based sample of middle-aged subjects.

Kiviniemi AM, Tulppo MP, Hautala AJ, Perkiömäki JS, Ylitalo A, Kesäniemi YA, Ukkola O, Huikuri HV.

Am J Cardiol. 2014 Aug 15;114(4):571-6. doi: 10.1016/j.amjcard.2014.05.032. Epub 2014 Jun 6.

PMID:
25015692
27.

Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation.

Gunn J, Kuttila K, Kiviniemi T, Ylitalo A, Biancari F, Juvonen T, Airaksinen KE.

Ann Med. 2014 Aug;46(5):330-4. doi: 10.3109/07853890.2014.907025. Epub 2014 May 9.

PMID:
24813457
28.

Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.

Nammas W, Raatikainen MJ, Korkeila P, Lund J, Ylitalo A, Karjalainen P, Virtanen V, Koivisto UM, Utriainen S, Vasankari T, Koistinen J, Airaksinen KE.

Ann Med. 2014 May;46(3):177-81. doi: 10.3109/07853890.2014.894285.

PMID:
24785546
29.

Transthoracic echocardiography for non-invasive assessment of coronary vasodilator function after DES implantation.

Varho V, Karjalainen PP, Ylitalo A, Airaksinen JK, Mikkelsson J, Sia J, Pietilä M, Kiviniemi TO.

Eur Heart J Cardiovasc Imaging. 2014 Sep;15(9):1029-34. doi: 10.1093/ehjci/jeu059. Epub 2014 Apr 21.

PMID:
24755162
30.

Heart rate variability findings as a predictor of atrial fibrillation in middle-aged population.

Perkiömäki J, Ukkola O, Kiviniemi A, Tulppo M, Ylitalo A, Kesäniemi YA, Huikuri H.

J Cardiovasc Electrophysiol. 2014 Jul;25(7):719-24. doi: 10.1111/jce.12402. Epub 2014 Apr 9.

PMID:
24602026
31.

Response to letters regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".

Pessi T, Karhunen V, Karjalainen PP, Ylitalo A, Airaksinen JK, Niemi M, Pietila M, Lounatmaa K, Haapaniemi T, Lehtimäki T, Laaksonen R, Karhunen PJ, Mikkelsson J.

Circulation. 2013 Oct 8;128(15):e237-8. doi: 10.1161/CIRCULATIONAHA.113.004701. No abstract available.

PMID:
24100488
32.

Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.

Romppanen H, Nammas W, Kervinen K, Airaksinen JK, Pietilä M, Rivero-Crespo F, Debelder A, Tedjokusumo P, Mikkelsson J, Ylitalo A, Karjalainen PP.

Ann Med. 2013 Nov;45(7):488-93. doi: 10.3109/07853890.2013.833390. Epub 2013 Sep 13.

PMID:
24032547
33.

Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.

Karjalainen P, Kiviniemi TO, Lehtinen T, Nammas W, Ylitalo A, Saraste A, Mikkelsson J, Pietila M, Biancari F, Airaksinen JK.

Int J Cardiovasc Imaging. 2013 Dec;29(8):1693-703. doi: 10.1007/s10554-013-0285-8. Epub 2013 Aug 31. Erratum in: Int J Cardiovasc Imaging. 2013 Dec;29(8):1915. Kiviniemi, Tuomas O [added]; Lehtinen, Tuomas [added]; Nammas, Wail [added]; Ylitalo, Antti [added]; Saraste, Antti [added]; Mikkelsson, Jussi [added]; Pietila, Mikko [added]; Biancari, Fausto [added]; Airaksinen, Juhani K E [added].

PMID:
23996244
34.

Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.

Airaksinen KE, Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F, Hartikainen JE.

J Am Coll Cardiol. 2013 Sep 24;62(13):1187-92. doi: 10.1016/j.jacc.2013.04.089. Epub 2013 Jul 10.

35.

Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.

Airaksinen KE, Korkeila P, Lund J, Ylitalo A, Karjalainen P, Virtanen V, Raatikainen P, Koivisto UM, Koistinen J.

Int J Cardiol. 2013 Oct 9;168(4):3679-82. doi: 10.1016/j.ijcard.2013.06.022. Epub 2013 Jul 9.

PMID:
23849104
36.

Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study.

Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JE, Airaksinen KE.

Europace. 2013 Oct;15(10):1432-5. doi: 10.1093/europace/eut106. Epub 2013 May 17.

PMID:
23687124
37.

Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.

Maeng M, Holm NR, Erglis A, Kumsars I, Niemelä M, Kervinen K, Jensen JS, Galløe A, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Christiansen EH, Lassen JF, Thuesen L; Nordic-Baltic Percutaneous Coronary Intervention Study Group.

J Am Coll Cardiol. 2013 Jul 2;62(1):30-4. doi: 10.1016/j.jacc.2013.04.015. Epub 2013 May 1.

38.

Vascular healing early after titanium-nitride-oxide-coated stent implantation assessed by optical coherence tomography.

Annala AP, Lehtinen T, Kiviniemi TO, Ylitalo A, Nammas W, Karjalainen PP.

J Invasive Cardiol. 2013 Apr;25(4):186-9.

39.

[Treatment of acute ST-elevation myocardial infarction].

Ylitalo A, Pietilä M.

Duodecim. 2013;129(3):285-92. Review. Finnish.

PMID:
23457777
40.

Bacterial signatures in thrombus aspirates of patients with myocardial infarction.

Pessi T, Karhunen V, Karjalainen PP, Ylitalo A, Airaksinen JK, Niemi M, Pietila M, Lounatmaa K, Haapaniemi T, Lehtimäki T, Laaksonen R, Karhunen PJ, Mikkelsson J.

Circulation. 2013 Mar 19;127(11):1219-28, e1-6. doi: 10.1161/CIRCULATIONAHA.112.001254. Epub 2013 Feb 15.

PMID:
23418311
41.

Early vascular healing after endothelial progenitor cell capturing stent implantation.

Lehtinen T, Kiviniemi TO, Ylitalo A, Mikkelsson J, Airaksinen JK, Karjalainen PP.

J Invasive Cardiol. 2012 Dec;24(12):631-5.

42.

Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.

Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, Nyman K, Nammas W, Airaksinen KE, Karjalainen PP.

Int J Cardiol. 2013 Sep 30;168(2):1214-9. doi: 10.1016/j.ijcard.2012.11.060. Epub 2012 Dec 3.

PMID:
23218575
43.

Lack of genitourinary physical examination before urologic consultation--a quality of care issue.

Ylitalo AW, Ylitalo KR, Santucci RA.

Urology. 2012 Dec;80(6):1243-6. doi: 10.1016/j.urology.2012.07.087.

PMID:
23206768
44.

Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic Intravascular Ultrasound Study (NIVUS).

Kosonen P, Vikman S, Jensen LO, Lassen JF, Harnek J, Olivecrona GK, Erglis A, Fossum E, Niemelä M, Kervinen K, Ylitalo A, Pietilä M, Aaroe J, Kellerth T, Saunamäki K, Thayssen P, Hellsten L, Thuesen L, Niemelä K.

Int J Cardiol. 2013 Sep 30;168(2):1010-6. doi: 10.1016/j.ijcard.2012.10.033. Epub 2012 Nov 17.

PMID:
23164593
45.

Late stent thrombosis of a second-generation drug- eluting stent.

Karjalainen PP, Nammas W, Ylitalo A.

J Invasive Cardiol. 2012 Oct;24(10):E225-7.

46.

High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults.

Vasunta RL, Kesäniemi YA, Ylitalo AS, Ukkola OH.

J Hypertens. 2012 Oct;30(10):2015-9. doi: 10.1097/HJH.0b013e3283576faf.

PMID:
22940679
47.

A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.

Karjalainen PP, Niemelä M, Airaksinen JK, Rivero-Crespo F, Romppanen H, Sia J, Lalmand J, de Bruyne B, Debelder A, Carlier M, Nammas W, Ylitalo A, Hess OM; BACE-ACS study investigators.

EuroIntervention. 2012 Jul 20;8(3):306-15. doi: 10.4244/EIJV8I3A49.

48.

[Myocardial infarct during pregnancy].

Pietilä M, Ylitalo A, Airaksinen J.

Duodecim. 2012;128(5):514-7. Finnish.

PMID:
22486067
49.

Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.

Kiviniemi T, Karjalainen P, Pietilä M, Ylitalo A, Niemelä M, Vikman S, Puurunen M, Biancari F, Airaksinen KE.

Am J Cardiol. 2012 Jul 1;110(1):30-5. doi: 10.1016/j.amjcard.2012.02.045. Epub 2012 Mar 29.

PMID:
22464216
50.

Gender-based analysis of the 3-year outcome of bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: an insight from the TITAX-AMI trial.

Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, Nyman K, Nammas W, Airaksinen KE, Karjalainen PP.

J Invasive Cardiol. 2012 Mar;24(3):104-8.

Supplemental Content

Loading ...
Support Center